George Stepan

2.2k total citations
22 papers, 1.0k citations indexed

About

George Stepan is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, George Stepan has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 12 papers in Virology and 8 papers in Molecular Biology. Recurrent topics in George Stepan's work include HIV/AIDS drug development and treatment (14 papers), HIV Research and Treatment (12 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). George Stepan is often cited by papers focused on HIV/AIDS drug development and treatment (14 papers), HIV Research and Treatment (12 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). George Stepan collaborates with scholars based in United States, Czechia and Belgium. George Stepan's co-authors include K L Kaffka, Carolyn A. Campen, Kenneth Kolinsky, Kim W. McIntyre, P L Kilian, W R Benjamin, R Chizzonite, Tomáš Cihlář, Helen Yu and Tian Yang and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

George Stepan

22 papers receiving 988 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
George Stepan United States	14	445	299	281	181	172	22	1.0k
Carolyn Napier United Kingdom	12	485 1.1×	433 1.4×	653 2.3×	167 0.9×	239 1.4×	19	1.3k
Alonso Heredia United States	23	609 1.4×	320 1.1×	693 2.5×	413 2.3×	435 2.5×	71	1.6k
Vladimir T. Valuev-Elliston Russia	13	174 0.4×	285 1.0×	107 0.4×	246 1.4×	80 0.5×	40	764
Katsunori Takashima Japan	11	209 0.5×	242 0.8×	258 0.9×	155 0.9×	452 2.6×	12	963
Herwig Koppensteiner Germany	16	218 0.5×	343 1.1×	440 1.6×	154 0.9×	278 1.6×	25	1.0k
Makoto Matsukura Japan	22	518 1.2×	1.1k 3.6×	451 1.6×	304 1.7×	226 1.3×	78	2.2k
Mireille Laforge France	19	306 0.7×	604 2.0×	177 0.6×	488 2.7×	466 2.7×	34	1.8k
Christina Gavegnano United States	17	472 1.1×	183 0.6×	500 1.8×	173 1.0×	237 1.4×	32	975
Serkan Sertel Germany	19	218 0.5×	443 1.5×	447 1.6×	288 1.6×	484 2.8×	43	1.6k
Brigitte Allard United States	15	242 0.5×	259 0.9×	282 1.0×	97 0.5×	168 1.0×	24	743

Countries citing papers authored by George Stepan

Since Specialization

Citations

This map shows the geographic impact of George Stepan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Stepan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Stepan more than expected).

Fields of papers citing papers by George Stepan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Stepan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Stepan. The network helps show where George Stepan may publish in the future.

Co-authorship network of co-authors of George Stepan

This figure shows the co-authorship network connecting the top 25 collaborators of George Stepan. A scholar is included among the top collaborators of George Stepan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Stepan. George Stepan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baszczyňski, Ondřej, Martin Kaiser, Martin Dračínský, et al.. (2023). Design and Synthesis of Novel HIV-1 NNRTIs with Bicyclic Cores and with Improved Physicochemical Properties. Journal of Medicinal Chemistry. 66(3). 1761–1777. 11 indexed citations

Subramanian, Raju, Jennifer Tang, Jim Zheng, et al.. (2023). Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral Agent. Molecular Pharmaceutics. 20(12). 6213–6225. 27 indexed citations

Xu, Yili, Ona Barauskas, Darius Babusis, et al.. (2020). Off-Target In Vitro Profiling Demonstrates that Remdesivir Is a Highly Selective Antiviral Agent. Antimicrobial Agents and Chemotherapy. 65(2). 41 indexed citations

Dejmek, Milan, Ondřej Baszczyňski, David Šaman, et al.. (2019). Synthesis and anti-human immunodeficiency virus activity of substituted (o,o-difluorophenyl)-linked-pyrimidines as potent non‐nucleoside reverse transcriptase inhibitors. Antiviral chemistry & chemotherapy. 27. 2664945753–2664945753. 6 indexed citations

Zheng, Jim, Stephen R. Yant, Shekeba Ahmadyar, et al.. (2018). 539. GS-CA2: A Novel, Potent, and Selective First-In-class Inhibitor of HIV-1 Capsid Function Displays Nonclinical Pharmacokinetics Supporting Long-Acting Potential in Humans. Open Forum Infectious Diseases. 5(suppl_1). S199–S200. 12 indexed citations

Šimon, Petr, Ondřej Baszczyňski, David Šaman, et al.. (2016). Novel (2,6-difluorophenyl)(2-(phenylamino)pyrimidin-4-yl)methanones with restricted conformation as potent non-nucleoside reverse transcriptase inhibitors against HIV-1. European Journal of Medicinal Chemistry. 122. 185–195. 14 indexed citations

Mulato, Andrew, Derek Hansen, Danielle Porter, et al.. (2016). Rapid In Vitro Evaluation of Antiretroviral Barrier to Resistance at Therapeutic Drug Levels. AIDS Research and Human Retroviruses. 32(12). 1237–1247. 5 indexed citations

Feng, Joy Y., Yili Xu, Ona Barauskas, et al.. (2015). Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C Virus. Antimicrobial Agents and Chemotherapy. 60(2). 806–817. 62 indexed citations

Callebaut, Christian, George Stepan, Tian Yang, & Michael D. Miller. (2015). In Vitro Virology Profile of Tenofovir Alafenamide, a Novel Oral Prodrug of Tenofovir with Improved Antiviral Activity Compared to That of Tenofovir Disoproxil Fumarate. Antimicrobial Agents and Chemotherapy. 59(10). 5909–5916. 74 indexed citations

10.

Navarro, Gabriel, George Stepan, Angela Tsai, et al.. (2015). Abyssomicin 2 Reactivates Latent HIV-1 by a PKC- and HDAC-Independent Mechanism. Organic Letters. 17(2). 262–265. 30 indexed citations

11.

Murry, Jeffrey P., Angela Tsai, Michael Graupe, et al.. (2015). Cyanotriazoles activate latent HIV and strongly synergize with proteasome inhibitors ex vivo in resting CD4 T cells from suppressed HIV + donors. Journal of Virus Eradication. 1. 12–12. 1 indexed citations

12.

Stepan, George, Angela Tsai, G.S. Jones, et al.. (2014). Study of Marine Natural Products Including Resorcyclic Acid Lactones from Humicola fuscoatra That Reactivate Latent HIV-1 Expression in an in Vitro Model of Central Memory CD4+ T Cells. Journal of Natural Products. 77(3). 618–624. 25 indexed citations

13.

Krečmerová, Marcela, Petr Jansa, Martin Dračínský, et al.. (2013). 9-[2-(R)-(Phosphonomethoxy)propyl]-2,6-diaminopurine (R)-PMPDAP and its prodrugs: Optimized preparation, including identification of by-products formed, and antiviral evaluation in vitro. Bioorganic & Medicinal Chemistry. 21(5). 1199–1208. 17 indexed citations

14.

Jansa, Petr, Ondřej Baszczyňski, Martin Dračínský, et al.. (2011). A novel and efficient one-pot synthesis of symmetrical diamide (bis-amidate) prodrugs of acyclic nucleoside phosphonates and evaluation of their biological activities. European Journal of Medicinal Chemistry. 46(9). 3748–3754. 55 indexed citations

15.

Clark, Robin D., Alam Jahangir, Lin Lin, et al.. (2005). Identification of a 5-HT4 receptor antagonist clinical candidate through side-chain modification. Bioorganic & Medicinal Chemistry Letters. 15(6). 1697–1700. 1 indexed citations

16.

Choppin, Agnès, et al.. (2002). Effect of YM-44781, YM-44778 and YM-49598, Novel Tachykinin Antagonists, in a Drug-Induced Bladder Contraction Model. Pharmacology. 65(2). 96–102. 5 indexed citations

17.

Daniels, Donald V., Joel R. Gever, Jeffrey R. Jasper, et al.. (1999). Human cloned α1A-adrenoceptor isoforms display α1L-adrenoceptor pharmacology in functional studies. European Journal of Pharmacology. 370(3). 337–343. 68 indexed citations

18.

Choppin, Agnès, George Stepan, Dana N. Loury, N. Watson, & Richard M. Eglen. (1999). Characterization of the muscarinic receptor in isolated uterus of sham operated and ovariectomized rats. British Journal of Pharmacology. 127(7). 1551–1558. 26 indexed citations

19.

McIntyre, Kim W., George Stepan, Kenneth Kolinsky, et al.. (1991). Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.. The Journal of Experimental Medicine. 173(4). 931–939. 254 indexed citations

20.

Heidemann, H., et al.. (1989). Effect of aminophylline on cisplatin nephrotoxicity in the rat. British Journal of Pharmacology. 97(2). 313–318. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact